Affiliation:
1. University Medical Center Goettingen
2. University Medical Center
3. Eberhard Karls University Tübingen
Abstract
Abstract
Background
Sarcopenia has a high prevalence among the aging population. Leading to falls and hospitalization, subsequently increasing healthcare costs while limiting the quality of life, sarcopenia is of tremendous socioeconomic importance. In sarcopenic muscle fibers, the E3 ubiquitin ligase F-Box Protein 32 (Fbxo32) is expressed at substantially higher levels, driving ubiquitin-proteasomal muscle protein degradation. As one of the key regulators of muscular equilibrium, the transcription factor Forkhead Box O3 (FOXO3) can increase the expression of Fbxo32, making it a possible target for regulation of this detrimental pathway.
Methods
To test this hypothesis, murine C2C12 myoblasts were transduced with AAVs carrying a plasmid for four specific siRNAs against Foxo3. Successfully transduced myoblasts were selected via FACS cell sorting to establish single clone cell lines. Sorted myoblasts were further differentiated into myotubes and stained for myosin heavy chain (MHC) by immunofluorescence. The resulting area was calculated. Myotube contractions were induced by electrical stimulation and quantified.
Results
We found an increased Foxo3 expression in satellite cells in human skeletal muscle and an age-related increase in Foxo3 expression in older mice in silico. We established an in vitro AAV-mediated FOXO3 knockdown on protein level. Surprisingly, the myotubes with FOXO3 knockdown displayed a smaller myotube size and a lower number of nuclei per myotube compared to control myotubes (AAV-transduced with a functionless control plasmid). During differentiation, a lower level of FOXO3 reduced the expression Fbxo32 within the first three days. Moreover, the expression of Myod1 and Myog via ATM and Tp53 was reduced. Functionally, the Foxo3 knockdown myotubes showed a higher contraction duration and time to peak.
Conclusions
Early Foxo3 knockdown seems to terminate the initiation of differentiation due to lack of Myod1 expression and mediates the inhibition of Myog. Subsequently, the myotube size is reduced and the excitability to electrical stimulation is altered.
Publisher
Research Square Platform LLC
Reference43 articles.
1. Sarcopenia: revised European consensus on definition and diagnosis;Cruz-Jentoft AJ;Age and Ageing,2019
2. The incidence of sarcopenia among hospitalized older patients: results from the Glisten study;Martone AM;J Cachexia Sarcopenia Muscle,2017
3. Bischoff-Ferrari HA, Orav JE, Kanis JA, Rizzoli R, Schlögl M, Staehelin HB, et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. 2015 Dec 1;26(12):2793–802.
4. Prevalence and prognostic significance in hospitalized patients;Gariballa S;Clinical Nutrition,2013
5. Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia;Beaudart C;J Cachexia Sarcopenia Muscle,2017
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献